Mitochondria and Doxorubicin-Induced Cardiomyopathy: A Complex Interplay

Cardiotoxicity has emerged as a major side effect of doxorubicin (DOX) treatment, affecting nearly 30% of patients within 5 years after chemotherapy. Heart failure is the first non-cancer cause of death in DOX-treated patients. Although many different molecular mechanisms explaining the cardiac dera...

Descripción completa

Detalles Bibliográficos
Autores principales: Schirone, Leonardo, D’Ambrosio, Luca, Forte, Maurizio, Genovese, Riccardo, Schiavon, Sonia, Spinosa, Giulia, Iacovone, Giuliano, Valenti, Valentina, Frati, Giacomo, Sciarretta, Sebastiano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266202/
https://www.ncbi.nlm.nih.gov/pubmed/35805084
http://dx.doi.org/10.3390/cells11132000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266202/
https://www.ncbi.nlm.nih.gov/pubmed/35805084
http://dx.doi.org/10.3390/cells11132000

Ejemplares similares